WHO ICTRP trial
The effect of astaxanthin supplementation in patients with coronary artery…
IRCT20201227049857N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20201227049857N1 |
|---|---|
| Public title | The effect of astaxanthin supplementation in patients with coronary artery disease |
| Scientific title | The effects of Astaxanthin supplementation on serum levels of Sirtuin1? TNF-a? metabolic parameters, body composition and nutritional status in patients with coronary artery disease. |
| Primary sponsor | Tabriz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Coronary Artery Disease. |
| Interventions | Intervention 1: Intervention group:. Intervention 2: Control group:. |
| Registration date | Feb 19, 2021 |
| Target size | 44 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: